2-Bromo-5,6-dihydro-4H-cyclopenta[b]thiophen-4-one

Catalog No.: 
ACKRAQ382
CAS No.: 
1369353-77-4
Molecular Formula: 
C7H5BrOS
Molecular Weight: 
217.09
2-Bromo-5,6-dihydro-4H-cyclopenta[b]thiophen-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$181.00InquiryInquiry
50mg95%$319.00InquiryInquiry
100mg95%$468.00In stockInquiry
250mg95%$658.00In stockInquiry
1g95%$2188.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-5,6-dihydro-4H-cyclopenta[b]thiophen-4-one
IUPAC Name2-Bromo-5,6-dihydro-4H-cyclopenta[b]thiophen-4-one
MDL No.MFCD22037360
Molecular FormulaC7H5BrOS
Molecular Weight217.09
SMILESO=C1C2C=C(SC=2CC1)Br
InChI KeyYSGWNYYXJIIWDG-UHFFFAOYSA-N
Synonym2-bromo-4H,5H,6H-cyclopenta[b]thiophen-4-one;2-Bromo-5,6-dihydro-4H-cyclopenta[b]thiophen-4-one;4H-Cyclopenta[b]thiophen-4-one, 2-bromo-5,6-dihydro-
CAS No.1369353-77-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKRAQ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRAQ382 route product structure diagram
    ACKRAQ3821369353-77-4In Stock
Inquiry

2. ACKRAQ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRAQ382 route product structure diagram
    ACKRAQ3821369353-77-4In Stock
Inquiry

3. ACKRAQ382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKRAQ382 route product structure diagram
    ACKRAQ3821369353-77-4In Stock
Inquiry

Comments (0)